Certified by Founder Lodge
Ancilia Biosciences
![Ancilia Biosciences](/images/flags/US.png)
START UP
1 Disclosed Funding Rounds $4,200,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
Date | Round | Raised | Participating Investors |
---|---|---|---|
August, 29 ,2024 | Unknown | $4,200,000 |